Anish Bhatnagar - 25 Jan 2023 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Chief Executive Officer, Director
Signature
/s/ Anish Bhatnagar
Issuer symbol
SLNO
Transactions as of
25 Jan 2023
Transactions value $
$0
Form type
4
Filing time
27 Jan 2023, 17:10:35 UTC
Previous filing
14 Oct 2022
Next filing
10 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLNO Employee stock option (right to buy) Award $0 +115,000 $0 115,000 25 Jan 2023 Common Stock 115,000 $2.41 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One forty-eighth of the shares subject to the option shall vest on February 1, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date.